The effect of planned walking on fatigue of patients with acute leukemia
Not Applicable
- Conditions
- Acute Myeloid Leukemia.Acute myeloblastic leukemia
- Registration Number
- IRCT20091017002599N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
being 18 years old and over
being diagnosed with acute AML or the recurrence of AML
taking part in at least two chemotherapy sessions
Exclusion Criteria
history of underlying diseases including cardiovascular diseases, diabetes mellitus and hypertension and any other cancers
Inability to attend walking tours
Unstable hemodynamic status
Hospital discharge or death
Life expectancy less than a month
Uncontrollable pain
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The score obtained from The Brief Fatigue Questionnaire (BFI). Timepoint: Fatigue measurement at the beginning of the study, 5 and 10 days after the planned walking. Method of measurement: The Brief Fatigue Questionnaire (BFI).
- Secondary Outcome Measures
Name Time Method Fatigue interference with everyday life activities. Timepoint: Before the intervention, 5 and 10 days after the intervention. Method of measurement: The Brief Fatigue Questionnaire (BFI).